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Abstract
Summary Patients with hip fractures experience reduced health-related quality of life and have a reduced life expectancy.
Patients’ utilization of healthcare leads to costs to society. The results of the study can be used in future economic evaluations
of treatments for hip fractures.
Purpose Hip fractures are associated with high mortality, reduced quality of life, and increased healthcare utilization, leading to
an economic burden to society. The purpose of this study is to determine the burden of illness of hip fractures in elderly Dutch
patients for specific time periods after surgery.
Methods Patients with a hip fracture above the age of 65 were included in the study. In the 1-year period after surgery, patients
were asked to complete a set of questionnaires pre-injury (retrospectively), and 1 week, 1 month, 3 months, 6 months and
12 months after surgery. The set of questionnaires included the Euroqol 5D (EQ-5D-3L), the iMTA Medical Consumption
Questionnaire (iMCQ) and iMTA Productivity Cost Questionnaire (iPCQ). Health-related quality of life was calculated using
Dutch tariffs. Costs were calculated using the methodology described in the Dutch costing manual.
Results Approximately 20% of patients with a hip fracture died within 1 year. Health-related quality of life was significantly
reduced compared to pre-injury values, and patients did not recover to their pre-injury values within 1 year. Total costs in the first
year after injury were €27,573, of which 10% were due to costs of the procedure (€2706). Total follow-up costs (€24,876) were
predominantly consisting of healthcare costs. Monthly costs decreased over time.
Conclusions Hip fractures lead to a burden to patients, resulting frommortality and health-related quality of life reductions, and to
society, due to (healthcare) costs. The results of this study can be used in future economic evaluations.
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Introduction
Hip fracture is a severe fracture attributable to bone fragility
and predominantly affects an already frail population. A dis-
tinction can be made between low-energetic and high-
energetic traumas, with low-energetic traumas affecting an
older population. The burden of hip fractures on healthcare
and society is very high. In 2010, the number of hip fractures
in the European Union was over 600,000 [1]. Given the age-
ing population, the number of hip fractures is projected to
grow in the coming decades [2]. Hip fractures can result in
complications, chronic pain, reduced quality of life and pre-
mature death [3–5]. Next to the clinical burden to patients, hip
fractures lead to medical consumption, including hospitaliza-
tions, and associated healthcare costs. In 2010, the estimated
economic burden of hip fractures in the European Union due
to use of healthcare services was €19 billion [1]. In addition to
the burden on the healthcare budget, a patient’s social envi-
ronment is likely to be affected, because of emotional reasons
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and because of an increased need for informal care [6].
Finally, hip fractures potentially result in productivity losses,
particularly due to a patient’s inability to perform unpaid
work, as the proportion of patients with paid work is generally
small due to the population’s high age. The prevention and
optimal treatment of hip fractures are therefore of crucial im-
portance. The efficiency of prevention and treatment options
is, given the economic burden, likely to be an increasingly
important factor deciding on the care pathway. For this pur-
pose, data on both cost and effects are required to inform
health economic models. One of the benefits of using models
for economic evaluations is their ability to extrapolate out-
comes beyond the observed period. For this purpose, it is
crucial that the pattern of costs and health-related quality of
life (HRQOL) over time is identified, because costs and
HRQOL can be different directly after surgery than after a
period of time.
Previous publications on per patient healthcare costs of hip
fractures in the Netherlands have reported cost estimates be-
tween €19,741 and €26,355 (inflation corrected to 2018
values) [7–10]. Next to costs, information on HRQOL is cru-
cial for health economic studies. HRQOL is generally present-
ed in a utility value, which scores HRQOL on a scale from 0
(death) to 1 (perfect health). The impact of hip fractures on
HRQOL has previously been assessed in the Netherlands in
other studies. A study in the period 2001–2002 showed that
utility scores for patients with hip fractures were severely re-
duced compared to the average Dutch population: 2.5 months
after injury, the average utility was 0.43 and 0.67 after
24 months [11]. More recent Dutch studies did not report
utility values but have been reported in international studies.
A recent systematic review showed that HRQOL deteriorates
in the first period after a hip fracture, after which patients
recover to a level below their pre-injury level [5]. The primary
objective of the current study is to provide a comprehensive
overview of the burden of illness of hip fractures in an elderly
population in the Netherlands. For this purpose, we examine,
over a period of 1 year after hip fracture, life expectancy,
HRQOL and healthcare and productivity costs in a sample
of Dutch elderly patients with a hip fracture who underwent
surgery. A distinction in monthly costs and utilities over time
will be examined, so that these estimates can be used in
model-based economic evaluations.
Methods
Dataset
The study used the Brabant Injury Outcome Surveillance
(BIOS) database, a multicentre observational follow-up cohort
study, which is described elsewhere [12]. Data were collected
in the period August 2015–November 2016. For the current
study, the subset of hip fracture patients was selected. The
dataset contained 821 patients with hip fracture over the age
of 65 with a hip fracture that underwent surgery. Patients were
followed for 1 year, with measurements of pre-injury (T0;
measured retrospectively), and 1 week (T1), 1 month (T2),
3 months (T3), 6 months (T4) and 12months (T5) after injury.
The dataset contained information on survival, HRQOL, frail-
ty and healthcare costs and productivity costs. Only patients
who participated in the prospective study were included in the
sample. Patients that died during hospitalization (n = 2) were
excluded from the study, since they were unable to provide
informed consent after surgery. Furthermore, three patients
with pathological fractures were excluded. No patients were
excluded because of language barrier, although language bar-
rier was an exclusion criterion. Ethical approval was received
from the Medical Ethics Committee Brabant, the Netherlands
(NL50258.028.14). Informed consent was obtained from all
individual participants included in the study.
Measurement and valuation of health-related quality
of life
HRQOL was expressed in utilities, derived from the EQ-5D-
3L. This generic instrument is used to measure health status
using five health dimensions (mobility, self-care, usual activ-
ities, pain/discomfort and anxiety/depression), each dimen-
sion having three levels [13]. Health status descriptions from
the EQ-5D can be valued using tariffs from preference elici-
tation studies to calculate utilities, which can be used in eco-
nomic evaluations. Utility scores were derived from the EQ-
5D using the Dutch value set [14]. Negative values were also
possible and represent health states worse than death. Utility
values calculated with the Dutch value set range from − 0.329
to 1.000.
Measurement and valuation of costs
Costs of the surgical procedure were estimated using a micro-
costing study. For this purpose, the time duration of all hip
surgery procedures in 2017 in level 1 trauma centre Elisabeth-
Tweesteden Ziekenhuis (ETZ, Tilburg, the Netherlands) was
used. The costs associated with using the operation room (per
minute, including overhead costs) and costs of prostheses
were based on information from the financial department of
ETZ. Involvement of medical personnel was based on expert
opinion and valued using the Dutch costing manual [15].
Medical consumption was measured with the iMTA
Medical Consumption Questionnaire (iMCQ) [16]. The ques-
tionnaire included questions on utilization of home care, gen-
eral practitioner, rehabilitation, long-term care, psychologist
and paramedical care. Except for the initial hospitalization
resultant of the hip fracture and one outpatient visit following
surgery (based on expert opinion), hospital costs were not
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included in the database. Dutch health economic guidelines
require studies to be carried out from a societal perspective,
meaning that all costs and effects should be included in the
analyses [17]. Therefore, not only healthcare costs were in-
cluded in the study. The iMTA Productivity Costs
Questionnaire (iPCQ) was used to measure productivity costs
[16, 18]. Data on unpaid work (e.g. household activities) were
not collected. Healthcare consumption and productivity losses
were valued using the most recent update of the Dutch costing
manual [15]. The friction cost method was used to establish
productivity costs. Prices were indexed to 2018 price level.
Data on informal care and associated costs were not available.
Missing data
To make optimal use of available data, missing data were
imputed. For this purpose, HRQOL was imputed using
multiple imputation by chained equations [19] and line-
ar interpolation. Costs were imputed using multiple im-
putation and mean imputation for individual items. Full
details about the imputation procedures are provided in
the appendix.
Statistical analyses
Utility values were presented for patients alive at each specific
time point. In addition to utility values, QALYs were calculat-
ed by combining survival and quality of life. Since the follow-
up of the current study was 1 year and utilities are maximized
at 1.00, the maximum QALY value in this study was 1.00.
Costs were presented as total annual costs and average month-
ly costs for specific time periods. Total annual costs include
cost estimates for patients that died during the study period.
Subgroup analyses were performed with respect to 1-year
survival (whether patients survived the first year after injury or
not), gender, age (age groups of 65–69, 70–79, 80–89 and ≥
90), comorbidity, pre-injury living situation and frailty.
Statistical analyses were performed using Stata 15.1
(StataCorp).
Results
The average age in the patient population was 80 years (SD of
8.63; range 65–101). The majority of patients were female.
More than 80% of patients had one or more comorbidities at
moment of injury. Most common comorbidities were heart
malfunctions (29% of patients), arthrosis (28%), dementia
(23%) and osteoporosis (18%). Pre-injury HRQOL was 0.72
(SD of 0.28; range of − 0.204 to 1.00). Half of the patients
were identified as frail on the Groningen Frailty Indicator
(GFI). A total of 21% of patients lived in an institution pre-
injury (Table 1.)
Survival and health-related quality of life
Survival data were available for 820 patients. The survival rate
in the first 30 days after injury was 99.5% [95%CI: 98.7–99.8].
One-year survival was 83.3% [95% CI: 80.3–86.0]. Mortality
of 80-year-olds in the Dutch population is 4.3% [21].
Pre-injury HRQOL data were available for 625 patients.
Pre-injury HRQOL for this patient population was on average
0.72. This is approximately 13% lower than the Dutch popu-
lation norm utility value of 0.83 of people over the age of 75
[22]. Figure 1 shows the development of utility values in the
first year after injury. Hip fractures resulted in a sharp decrease
in HRQOL compared to patients’ pre-injury utility value.
With time, patients gradually recovered from the hip fracture,
but their utility value after 1 year was still substantially lower
than their pre-injury utility.
The average QALY value for patients in the year during
follow-up was 0.528 (95% CI: 0.504–0.553).
Costs
Table 2 shows that total costs following the first year after a hip
fracturewere €27,573. Cost of the surgical procedure was €2706
(range of €1734 – €4397), accounting for 10% of total costs.
Data on costs in the period following surgery were available for
663 patients in the BIOS study. Table 2 shows that average total
healthcare costs in the year following injury were €24,760
(range of €21,113–€28,406), accounting for 90% of total costs.
Productivity costs were minor in the year following a hip frac-
ture, due to the high age of the population. The first month after
injury was the most costly; healthcare costs accumulated to
€6932. The majority of costs in the first month were related to
hospitalizations (> 50% of total monthly costs). The average
length of stay in the hospital following the fracture was 8.6 days
(median of 7; range of 1–63). The second largest cost compo-
nent was long-term care stay (> 40%). Almost 54% of patients
returned home after hospital discharge. As time progresses, av-
erage monthly costs decreased, from over €3193 in months 2
and 3 after injury to €1206 in months 7 to 12 after injury. In
months 7 to 12 after injury, the vast majority of monthly
costs (> 80%) were due to long-term care stay.
Table 1 Patient characteristics
Variable Mean Std. err.
Age 80.2 0.349
Gender (% female) 70.3% 0.018
One or more comorbidities pre-injury 82.5% 0.015
Health-related quality of life pre-injury 0.722 0.011
Frail elderly (GFI ≥ 4) pre-injury 52.1% 0.021
Living in an institution pre-injury 21.2% 0.016
GFI: Groningen Frailty Indicator [20]
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Subgroup analyses
Table 3 presents the results of the subgroup analyses.
Although follow-up costs for patients who died within the
study period were higher than for patients who survived the
first year after injury, the confidence intervals around these
estimates were overlapping. Male patients incurred signifi-
cantly more QALYs than female patients. Younger patients
on average had lower follow-up costs and more QALYs than
older patients. Costs for patients with comorbidities were
higher and health effects than for patients without comorbid-
ities. Confidence intervals of costs for patients living at home
pre-injury and institutionalized patients overlapped. QALYs
were significantly higher for patients living at home pre-inju-
ry. Costs for frail elderly patients were higher than for non-
frail patients. QALYs were significantly higher for non-frail
patients.
Discussion
This study assessed the burden of illness of hip fractures.
Approximately 20% of patients died within 1 year. Patients
experienced reduced HRQOL and did not recover to their pre-
injury HRQOL level within 1 year. Average annual healthcare
costs were €27,573, of which 10% was related to the surgical
procedure and 90%was due to follow-up costs in the first year
after injury. Follow-up costs were found to be concentrated in
the first period after injury.
Comparison to other studies
The findings on the pattern of HRQOL after a hip fracture in
the current study concur with earlier findings in a recent liter-
ature review, in that HRQOL is severely reduced after a hip
fracture and patients recover to a level below their pre-injury
HRQOL [5]. With respect to costs, other studies also found
that incremental costs declined over time since injury [9,
23–25]. Comparing international cost estimates is complicat-
ed due to international differences in, among others, unit cost
prices, inclusion of cost categories, finance systems,
healthcare pathways and patient populations.
Over the years, various studies assessed per patient costs of
hip fractures in the Netherlands. In 1999, per patient were
estimated to be €13,600 (inflation corrected to 2018:
€19,741) [7]. A study that collected data between 2003 and
2007, estimated healthcare costs of €18,233 (2018: €21,975)
[8]. Another study, with data collected between 2008 and
2011 estimated healthcare costs for the first year to be
23,869 (2018: €26,355) [9]. Using 2012 data, per patient
Table 2 Average costs (in euros)
Total costs Monthly follow-up costs
Total
costs
Procedure costs
(n = 321)
Annual
follow-up costs
(n = 663) *
Month 1
(n = 663) *
Months 2–3
(n = 652)
Months 4–6
(n = 621)
Months 7–12
(n = 598)
Mean Mean Mean Mean Range Mean Range Mean Range Mean Range
Medical costs 27,466 2706 24,760 6932 1005-18,134 3193 0–26,645 1770 0–20,489 1205 0–15,770
Productivity costs 107 N/a 107 61 0–10,125 16 0–2394 2 0–1551 1 0–849
Total 27,573 2706 24,867 6993 1005–18,134 3209 0–26,645 1773 0–20,489 1206 0–15,770
*Excluding procedure costs
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Fig. 1 Utility values for patients
with hip fracture over time
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healthcare costs were estimated to be €19,717 (2018:
€21,770), with additional costs due to lost productivity of
€34,518 (2018: €38,113) [10]. When comparing the results
of the current study to previous Dutch studies, the current
estimates of healthcare costs resemble findings in three of
these earlier studies [8–10]. The study by Meerding et al. es-
timated lower healthcare costs (€13,600; 2018 values
€19,741) for a period of 9 months after injury [7]. Costs were
lower than in the current study for multiple reasons: the
follow-up period was shorter than in the current study; insti-
tutionalized patients were excluded; and lower unit cost prices
were used. Productivity costs were previously estimated in
one Dutch study [10], and were much higher than estimated
in the current study, which was likely to be explained by the
high age of the patient population; only elderly patients were
included in the current study. As such, the majority of patients
was already retired and did not incur productivity costs from
paid work.
Limitations
Cost estimates of the surgical procedure were based on infor-
mation from one hospital only, supplemented with expert
opinion. This hospital is a level 1 trauma centre (i.e. the
highest level in the Netherlands), which might not be
representative for all hospitals in the Netherlands. Ideally,
multiple hospitals with varying levels of trauma care would
have been included, and expert input would have been re-
placed by observed parameter input on involvement of med-
ical personnel. Furthermore, procedure costs were not deter-
mined for the same patients who were included in the follow-
up cost study in BIOS. Combining the data into a single cost
estimate therefore assumes that the procedure costs can be
generalized to the patients in the BIOS study.
Besides hospital costs related to the surgical procedure and
an assumed one-time follow-up outpatient visit, hospital-
related resource use was not measured in the BIOS study.
Follow-up hospitalizations due to complications were not in-
cluded in the study either. This has resulted in an underesti-
mation of total costs. In addition, the dataset did not contain
information on informal care use. As such, costs related to
informal care could not be taken into account. An earlier study
in informal caregivers in a subsample of this patient popula-
tion showed that the use of informal care is substantial: the
vast majority of patients had received informal care (only 11%
of contact persons had never provided informal care); in the
first month after injury, patients on average received 50 h of
informal care per week, and after 6 months, patients received
25 h of informal care per week [6]. Such volumes of care are
associated with monthly costs of €2740 and €1370,
Table 3 Subgroup analyses
Number Total annual follow-up costs * QALYs
Mean 95% CI Mean 95% CI
All patients 625 €25,395 €21,569–€29,221 0.528 0.504–0.553
Deceased
Alive after 12 months 516 €23,909 €19,887–€27,931 0.601 0.578–0.624
Not alive after 12 months 109 €32,431 €22,462–€42,401 0.185 0.138–0.231
Gender
Male 187 €19,967 €13,960–€25,975 0.588 0.546–0.630
Female 438 €27,712 €22,845–€32,580 0.503 0.473–0.532
Age at injury
65–69 101 €9911 €3423–€16,399 0.714 0.673–0.754
70–79 177 €14,822 €9341–€20,303 0.634 0.591–0.676
80–89 246 €32,651 €26,203–€39,100 0.457 0.419–0.494
≥ 90 101 €41,733 €28,756–€54,711 0.333 0.277–0.388
Comorbidity
No comorbidities 108 €16,371 €10,337–€22,405 0.731 0.689–0.772
One comorbidity or more 511 €27,418 €22,882–€34,954 0.485 0.459–0.512
Pre-injury living situation
Home 486 €26,778 €22,198–€31,357 0.600 0.576–0.625
Institutionalized 132 €20,709 €12,562–€28,856 0.264 0.220–0.308
Frailty pre-injury
Non-frail (GFI < 4) 296 €16,044 €11,837–€20,250 0.725 0.701–0.749
Frail (GFI ≥ 4) 329 €33,942 €27,623–€40,260 0.348 0.318–0.379
*Excluding procedure costs
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respectively. Considering the size of total monthly costs cal-
culated in this study (€6933 and €1929 in months 1 and 6,
respectively), the absence of informal care costs is therefore an
important hiatus of the study. Finally, no data were collected
on productivity costs from unpaid work. Because the majority
of patients are already retired in this patient population, pro-
ductivity costs from paid work are limited. Performing unpaid
work is less age dependent, e.g. a patient aged 90might still be
able to perform household activities. Therefore, hip fractures
potentially lead to productivity losses and associated costs
from unpaid work in this patient population. Future research
could focus on this type of productivity losses.
Data were only collected from patients who were willing to
participate in the BIOS study. Patients that died during the
initial hospitalization after the hip fracture were therefore not
included in the sample. Likewise, patients with a very bad
prognosis might have opted not to participate in the study as
well. This selection bias might have led to an underestimation
of the burden of illness. This is apparent from the 30-day
survival rate in BIOS (99.5%), which is much lower than the
mortality in the total hip fracture populations with a 30-day
survival rate of 86.7% reported in a systematic literature
review [26].
Pre-injury HRQOL was determined retrospectively. This
may have caused recall bias. Prospective data collection is
not possible for pre-fracture patients. A recent systematic lit-
erature review showed that use of retrospective assessment of
pre-injury quality of life is the most commonmethod to collect
quality of life before injury; this method was used in 29 of 31
identified studies [27]. The use of population values has been
suggested as an alternative. However, these might not be an
adequate reflection of people with high risk of hip fractures, as
these high-risk people might already have more health prob-
lems and worse HRQOL compared to matched controls in the
overall population, as was indicated by the 13% lower utility
values of pre-injury found in this study.
Implications
The results of this burden of illness study can be used in future
economic evaluations in elderly patients with hip fractures. In
particular, the distinction of utility values and monthly costs at
different points in time after surgery can prove useful for
health economic modelling, especially when costs and effects
are extrapolated beyond the follow-up period of the study.
The objective of this study was to estimate the burden of
illness in elderly Dutch patients. Hence, we adhered to Dutch
guidelines with respect to quantifying utilities and costs. The
use of utility tariffs for other countries might result in different
utility values, but the pattern of HRQOL over time after injury
is unlikely to be different in other countries. This study used
the friction cost method to monetarize productivity losses
from paid work. Alternatively, the human capital method
could have been used. However, the results would be similar,
since the majority of patients in the sample were over the
retirement age.
Conclusions
Patients with hip fractures experience a significant burden in
the period after injury, as they experience an increased mor-
tality risk and reduced HRQOL. In addition, hip fractures lead
to a substantial economic burden, particularly due to costs of
healthcare consumption. The results of this study can be used
in future cost-effectiveness studies.
Funding information This study was supported by the Netherlands
Organization for Health Research and Development (ZonMw; grant no.
842004005). The authors would like to thank Katherina Abraham for her
support in conducting this study.
Compliance with ethical standards
Conflicts of interest None.
Open Access This article is licensed under a Creative Commons
Attribution 4.0 International License, which permits use, sharing,
adaptation, distribution and reproduction in any medium or format, as
long as you give appropriate credit to the original author(s) and the
source, provide a link to the Creative Commons licence, and indicate if
changes weremade. The images or other third party material in this article
are included in the article's Creative Commons licence, unless indicated
otherwise in a credit line to the material. If material is not included in the
article's Creative Commons licence and your intended use is not
permitted by statutory regulation or exceeds the permitted use, you will
need to obtain permission directly from the copyright holder. To view a
copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
References
1. Hernlund E, Svedbom A, Ivergård M, Compston J, Cooper C,
Stenmark J, McCloskey EV, Jönsson B, Kanis JA (2013)
Osteoporosis in the European Union: medical management, epide-
miology and economic burden. Arch Osteoporosis 8:136
2. Cooper C, Campion G, Melton LJ 3rd (1992) Hip fractures in the
elderly: a world-wide projection. Osteoporosis Int 2:285–289
3. Keene GS, Parker MJ, Pryor GA (1993) Mortality and morbidity
after hip fractures. BMJ 307:1248–1250
4. Johnell O, Kanis JA (2004) An estimate of the worldwide preva-
lence, mortality and disability associated with hip fracture.
Osteoporosis Int 15:897–902
5. Peeters CMM, Visser E, Van de Ree CLP, Gosens T, Den Oudsten
BL, De Vries J (2016) Quality of life after hip fracture in the elderly:
a systematic literature review. Injury 47:1369–1382
6. Van de Ree CLP, Ploegsma K, Kanters TA, Roukema JA, De Jongh
MAC, Gosens T (2018) Care-related quality of life of informal
caregivers of the elderly after a hip fracture. J Patient Report
Outcom 2:23
7. MeerdingWJ, Mulder S, Van Beeck EF (2006) Incidence and costs
of injuries in the Netherlands. Eur J Pub Health 16:271–277
   11 Page 6 of 7 Arch Osteoporos           (2020) 15:11 
8. Hartholt KA, Van Beeck EF, Polinder S, Van der Velde N, Van
Lieshout EM, Panneman MJ, Van der Cammen TJ, Patka P
(2011) Societal consequences of falls in the older population: inju-
ries, healthcare costs, and long-term reduced quality of life. J
Trauma 71:748–753
9. Burgers PTPW, Hoogendoorn M, Van Woensel EAC, Poolman
RW, Bhandari M, Patka P, Van Lieshout EMM, Trial
Investigators HEALTH (2016) Total medical costs of treating fem-
oral neck fracture patients with hemi- or total hip arthroplasty: a
cost analysis of a multicenter prospective study. Osteoporosis Int
27:1999–2008
10. Polinder S, Haagsma J, Panneman M, Scholten A, Brugmans M,
VanBeeck E (2016) The economic burden of injury: health care and
productivity costs of injuries in the Netherlands. Accident Anal
Prev 93:92–100
11. Polinder S, Van Beeck EF, Essink-Bot ML, Toet H, Looman CWN,
Mulder S,MeerdingWJ (2007) Functional outcome at 2.5, 5, 9, and
24 months after injury in the Netherlands. J Trauma Acute Care
Surg 62:133–141
12. De Jongh MA, Kruithof N, Gosens T, Van de Ree CL, De Munter
L, Brouwers L, Polinder S, Lansink KW, BIOS-group (2017)
Prevalence, recovery patterns and predictors of quality of life and
costs after non-fatal injury: the Brabant injury outcome surveillance
(BIOS) study. Inj Prev 23(59):2016–042032
13. Brooks R (1996) EuroQol: the current state of play. Health Policy
37:53–72
14. Lamers LM, McDonnell J, Stalmeier PFM, Krabbe PFM,
Busschbach JJV (2006) The Dutch tariff: results and arguments
for an effective design for national EQ-5D valuation studies.
Health Econ 15:1121–1132
15. Kanters TA, Bouwmans CAM, van der Linden N, Tan SS,
Hakkaart-van Roijen L (2017) Update of the Dutch manual for
costing studies in health care. PLoS One 12:e0187477
16. Bouwmans C, Hakkaart-van Roijen L, Koopmanschap M, Krol M,
Severens H, Brouwer W (2013) Manual iMTA medical cost ques-
tionnaire (iMCQ) [in Dutch: Handleiding iMTAmedical cost ques-
tionnaire (iMCQ)]
17. Zorginstituut Nederland (2016) Guideline for conducting economic
evaluations in healthcare [in Dutch: Richtlijn voor het uitvoeren van
economische evaluaties in de gezondheidszorg]
18. Bouwmans C, Krol M, Severens H, Koopmanschap M, Brouwer
W, Hakkaart-van Roijen L (2015) The iMTA productivity cost
questionnaire: a standardized instrument for measuring and valuing
health-related productivity losses. Value Health 18:753–758
19. White IR, Royston P, Wood AM (2011) Multiple imputation using
chained equations: issues and guidance for practice. Stat Med 30:
377–399
20. Schuurmans H, Steverink LS, Frieswijk N, Slaets JPJ (2004) Old or
frail: what tells us more? J Gerontol Series A Biol Sci Med Sci 59:
M962–M965
21. Centraal Bureau voor de Statistiek (2018) Life expectancy; gender,
age [in Dutch: Levensverwachting; geslacht, leeftijd]. 2018
22. Janssen B, Szende A (2014) Population norms for the EQ-5D
(2014) Self-reported population health: an international perspective
based on EQ-5D. Springer, 19-30
23. Marques A, Lourenço Ó, Da Silva JAP (2015) The burden of oste-
oporotic hip fractures in Portugal: costs, health related quality of life
and mortality. Osteoporosis Int 26:2623–2630
24. Leal J, Gray AM, Prieto-Alhambra D, Arden NK, Cooper C, Javaid
MK, Judge A, REFReSH study group (2016) Impact of hip fracture
on hospital care costs: a population-based study. Osteoporosis Int
27:549–558
25. Bessette L, Jean S, Lapointe-Garant M, Belzile EL, Davison KS,
Ste-Marie LG, Brown JP (2012) Direct medical costs attributable to
peripheral fractures in Canadian post-menopausal women.
Osteoporosis Int 23:1757–1768
26. Hu F, Jiang C, Shen J, Tang P, Wang Y (2012) Preoperative predic-
tors for mortality following hip fracture surgery: a systematic re-
view and meta-analysis. Injury 43:676–685
27. Scholten AC, Haagsma JA, Steyerberg EW, Van Beeck EF,
Polinder S (2017) Assessment of pre-injury health-related quality
of life: a systematic review. Popul Health Metrics 15:10
Publisher’s note Springer Nature remains neutral with regard to jurisdic-
tional claims in published maps and institutional affiliations.
Arch Osteoporos           (2020) 15:11 Page 7 of 7    11 
